Effects of N-acetylcysteine on the quality of life, anxiety and antioxidant indexes of patients with cardiovascular disease.

orestan University of Medical Sciences0 sites120 target enrollmentStarted: TBDLast updated: February 22, 2018

Conditions

Trial Snapshot

No summary available.

•1. patients with acute coronary syndrome, coronary artery disease, the treating physician to confirm the diagnosis reached.
•2 people (women and men) aged 65-18 years able to read and write their own.
•3. People who have the full consent to participate in research.
•4. People who have a history of these-acetylcysteine ??orally, by injection or inhalation during the first months of treatment have not.
•5 people without a history of hypersensitivity reactions after taking it approved acetylcysteine
•6. The people who received both medications or substances with antioxidant effects as vitamin E, A or vitamin A, E, vitamin C, at least one month before the quake
•7. People with a history of anti-anxiety drugs, have.
•8 people aged 65-18 years.
•9. The lack of disease HCV +, HBSAg +, HIV +, diabetes, kidney disease,
•10 of pregnancy
•Exclusion criteria
•(1) patients who can not understand the questions or did not have the time and location aware.
•2. Patients in the study were dissatisfied.
•3. Patients who withdrew during the study.
•4. People who do not consume drugs.
•5 people who died during the study.
•6. Individuals involved in the research program to improve the quality of life or reduce anxiety, such as health promotion, and rehabilitation and so on are.
•7 people in the business week by experts and researchers to track the phone call not to participate or not.
•8. ejection fraction less than 40% for the echocardiogram

Sponsor

orestan University of Medical Sciences